Cleared Traditional

K872961 - QTEST STREP

K872961 is the FDA 510(k) clearance for QTEST STREP by Quidel Corp.. It is a Class 1 Microbiology device (product code GTZ) cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K872961 · Quidel Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1987
Decision
62d
Days
Class 1
Risk

K872961 is an FDA 510(k) clearance for the QTEST STREP. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Quidel Corp. (San Diego, US). The FDA issued a Cleared decision on September 29, 1987 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Quidel Corp. devices

Submission Details

510(k) Number K872961 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 1987
Decision Date September 29, 1987
Days to Decision 62 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 102d · This submission: 62d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 47
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K872961.
BACTIGEN(R) GROUP B STREPTOCOCCUS TEST
K885003 · Armkel, LLC · Feb 1989
QUIDEL GROUP A STREP TEST
K883999 · Quidel Corp. · Oct 1988
KODAK SURECELL STREP A TEST KIT
K881457 · Eastman Kodak Company · Apr 1988
BACTIGEN GROUP B STREPTOCOCCUS-CS TEST
K872114 · Armkel, LLC · Aug 1987
DIRECTIGEN 1-2-3(TM) GROUP A STREP TEST
K872493 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1987
PATHO DX LATEX AGGLUTINATION STREP GROUPING KIT
K871831 · Diagnostic Products Corp. · Jun 1987